MedTrace Logo

Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study

NCT00632372 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2020-10-12

No results posted yet for this study

Summary

The purpose of this study is to collect and analyze electrical measurements, timing, and signals from a CRT-D device in heart failure patients who either already have an implanted left atrial pressure sensor or will undergo a simultaneous implantation of a left atrial pressure sensor and a CRT-D device. These devices may be placed at the same time or separately (staged procedure) at the discretion of the investigator. A comparison will be made between the information gathered from the CRT-D system and the information gathered by the left atrial pressure sensor.

Conditions

Interventions

DEVICE

Cardiac Resynchronization Therapy

Pacing of the left ventricle to resynchronize ventricular contraction.

DEVICE

HeartPOD™ System

Left atrial pressure monitoring.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Richard Troughton, MD · Christchurch Hospital - Christchurch, New Zealand

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2011-09-30
Completion
2015-12-31
FDA Device
Yes

Countries

  • United States
  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00632372 on ClinicalTrials.gov